Rolling coverage of the latest economic and financial news
Good morning, and welcome to our rolling coverage of the world economy, the financial markets, the eurozone and business.
Stock markets are heading higher this morning after AstraZeneca announced that its Covid-19 vaccine is effective in preventing infection from the virus.
The pharmaceuticals firm reported that trials of its vaccine developed by Oxford University showed it can be 90% effective in giving immunity to Covid-19.
The Covid-19 vaccine from AstraZeneca and Oxford University has shown 90% efficacy in global trials, similar to PfizerBioNTech and Moderna (around 95%)…and crucially it can be stored at fridge temperature. AZ will file for regulatory approval; wants to make 3bn doses next year
AstraZeneca/Oxford Covid-19 vaccine: no hospitalisations or severe cases of the disease were reported in those receiving the vaccine
These findings show that we have an effective vaccine that will save many lives. Excitingly, we’ve found that one of our dosing regimens may be around 90% effective and if this dosing regime is used, more people could be vaccinated with planned vaccine supply.
Today’s announcement is only possible thanks to the many volunteers in our trial, and the hard working and talented team of researchers based around the world.”
“We’ve got a a vaccine that is able to protect against coronavirus disease” Prof Andrew Pollard of the @OxfordVacGroup on the Oxford/AstraZeneca vaccine. Bright news on a dark November morning @BBCr4today